Here are the latest highlights on pancreatic cancer from reputable sources:
-
FDA expands access to a promising pancreatic cancer therapy, with early results showing a substantial improvement in survival for patients with advanced disease. This development reflects ongoing efforts to bring targeted and combination therapies to more patients.[3]
-
New FDA-approved treatment options for certain locally advanced or inoperable pancreatic cancers have emerged, including devices and drug combinations intended to broaden care where surgery isn’t possible. These approvals are part of a broader trend toward multimodal management and personalized medicine.[1]
-
Research and advocacy groups continue to report that pancreatic cancer outcomes remain challenging, with five-year survival around the low single digits and ongoing emphasis on early detection and innovative therapies. These voices also highlight the importance of supportive care, access to clinical trials, and dedicated funding for research.[1]
-
Large-scale studies and industry partnerships are accelerating progress in diagnostics, biomarkers, and precision medicine, including efforts to identify patients who may benefit from early intervention or targeted agents.[3][1]
-
Public-facing coverage and event-driven fundraising campaigns (e.g., PurpleStride) underscore the ongoing community focus on awareness, early detection, and research funding.[1]
If you’d like, I can:
- Pull the three most recent, verifiable news items with brief summaries and dates.
- Provide a quick primer on current treatment options by disease stage (resectable, locally advanced, metastatic).
- Create a simple timeline of notable recent breakthroughs and FDA milestones.
Would you like me to tailor this to a specific aspect (clinical trials, FDA approvals, or early detection)?
Citations:
- PanCAN blog updates and FDA-related news (latest items referenced above).[1]
- FDA-related coverage of new treatments for locally advanced or inoperable pancreatic cancer and related context.[3]
Sources
Read about the latest medical research concerning pancreatic cancer and other disorders of the pancreas. Consider new treatment options.
www.sciencedaily.comThe content you will find here includes updates, and insights that help raise awareness and support our mission in the fight against pancreatic cancer. Fri 1 May 2026 2 min read At Pancreatic Cancer Action, we see first-hand how powerful it is when people share their stories. Behind every diagnosis is a real person, a family, and a journey that deserves to be heard. Wed 11 Mar 2026 2 min read On Thursday 5th March, the Rare Cancers Bill received Royal Assent and officially became the Rare...
pancreaticcanceraction.orgPanCAN Media Relations Team Email Us 877-272-6226 Press Releases View Resources for the Media Follow us on social media.
pancan.orgPancreatic Cancer Latest News and Stories - Pancreatic Cancer Action Network
pancan.orgRead the latest about Pancreatic Cancer North America's awareness efforts, creative partnerships and organizational news.
pancreaticcancerna.orgdiv This spring, progress is taking shape across every part of our work. From advancing research to expanding programs that reach more patients than ever before, we are helping hope bloom. […] Since 1998, the Hirshberg Foundation has partnered with CancerCare to help families navigate the financial and emotional challenges that follow a pancreatic cancer diagnosis. With your generosity, we provide bi-annual […] A recent study published in Nature Communications, sponsored by the UCLA Health...
pancreatic.orgFor the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer. For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer. For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer. CBS News New York's Carolyn Gusoff reports. Around 3,000 people gathered at...
www.cbsnews.comFormer Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain. Former Sen. Ben Sasse, 54, called daraxonrasib "a miracle drug" that was allowing him to live longer and with less pain. A new pancreatic cancer treatment is showing good signs of longer life expectancies. Dr. Deirdre Cohen joins with more details. Former Sen. Ben Sasse, who was diagnosed with pancreatic cancer late last year, spoke to CBS News about why Congress is...
www.cbsnews.com